T1	tradename 104 112	ELESTRIN
T3	tradename 176 185	ELESTRIN.
T5	tradename 187 197	ElestrinTM
T7	activeingredient 199 208	estradiol
T9	dose 220 227	0.52 mg
T11	activeingredient 231 240	estradiol
T13	fdaapprovaldate 278 282	1975
T15	adversereaction 293 311	ENDOMETRIAL CANCER
T17	adversereaction 313 327	CARDIOVASCULAR
T19	adversereaction 329 338	DISORDERS
T21	adversereaction 340 353	BREAST CANCER
T23	adversereaction 358 375	PROBABLE DEMENTIA
T25	adversereaction 491 509	endometrial cancer
T27	tradename 1615 1623	ELESTRIN
T29	indication 1686 1721	Vasomotor Symptoms due to Menopause
T31	dose 1879 1886	0.52 mg
T33	activeingredient 1887 1896	estradiol
T35	dose 1956 1963	1.04 mg
T37	activeingredient 1964 1973	estradiol
T39	tradename 2058 2066	Elestrin
T41	dose 2124 2131	0.52 mg
T43	activeingredient 2135 2144	estradiol
T45	tradename 2626 2634	ELESTRIN
T47	adversereaction 2923 2942	gallbladder disease
T49	adversereaction 2980 2993	hypercalcemia
T51	adversereaction 2995 3009	loss of vision
T53	adversereaction 3018 3038	hypertriglyceridemia
T55	adversereaction 3042 3062	cholestatic jaundice
T57	adversereaction 3391 3408	breast tenderness
T59	adversereaction 3410 3422	metrorrhagia
T61	adversereaction 3424 3439	nasopharyngitis
T63	adversereaction 3445 3480	upper respiratory tract infections.
T65	company 3535 3539	Meda
T67	adversereaction 4316 4334	ENDOMETRIAL CANCER
T69	adversereaction 4336 4360	CARDIOVASCULAR DISORDERS
T71	adversereaction 4362 4375	BREAST CANCER
T73	adversereaction 4380 4397	PROBABLE DEMENTIA
T75	adversereaction 4398 4399	1
T77	indication 4452 4494	Severe Vasomotor Symptoms due to Menopause
T79	indication 4559 4594	Vasomotor Symptoms due to Menopause
T81	indication 4595 4596	3
T83	adversereaction 4676 4700	Cardiovascular Disorders
T85	adversereaction 4706 4725	Malignant Neoplasms
T87	adversereaction 4731 4748	Probable Dementia
T89	adversereaction 4754 4773	Gallbladder Disease
T91	adversereaction 4779 4792	Hypercalcemia
T93	adversereaction 4798 4818	Visual Abnormalities
T95	adversereaction 4893 4916	Elevated Blood Pressure
T97	adversereaction 4922 4942	Hypertriglyceridemia
T99	adversereaction 4991 5011	Cholestatic Jaundice
T101	adversereaction 5018 5032	Hypothyroidism
T103	adversereaction 5039 5054	Fluid Retention
T105	adversereaction 5061 5073	Hypocalcemia
T107	adversereaction 5080 5109	Exacerbation of Endometriosis
T109	adversereaction 6410 6428	ENDOMETRIAL CANCER
T111	adversereaction 6430 6454	CARDIOVASCULAR DISORDERS
T113	adversereaction 6457 6470	BREAST CANCER
T115	adversereaction 6475 6492	PROBABLE DEMENTIA
T117	adversereaction 6519 6537	Endometrial Cancer
T119	adversereaction 6569 6587	endometrial cancer
T121	adversereaction 6721 6744	endometrial hyperplasia
T123	adversereaction 6774 6793	endometrial cancer.
T125	adversereaction 7067 7091	Cardiovascular Disorders
T127	adversereaction 7096 7113	Probable Dementia
T129	adversereaction 7179 7201	cardiovascular disease
T131	adversereaction 7205 7213	dementia
T133	frequency 7502 7507	daily
T135	routeofadministration 7508 7512	oral
T137	dose 7540 7549	0.625 mg]
T139	adversereaction 7758 7775	probable dementia
T141	duration 7832 7841	5.2 years
T143	frequency 7860 7865	daily
T145	dose 7870 7879	0.625 mg)
T147	adversereaction 8561 8583	cardiovascular disease
T149	adversereaction 8587 8595	dementia
T151	duration 8868 8877	5.6 years
T153	frequency 8896 8901	daily
T155	routeofadministration 8902 8906	oral
T157	dose 8911 8920	0.625 mg)
T159	dose 8970 8977	2.5 mg]
T161	adversereaction 9169 9186	probable dementia
T163	duration 9243 9250	4 years
T165	frequency 9269 9274	daily
T167	dose 9279 9288	0.625 mg)
T169	adversereaction 9613 9635	invasive breast cancer
T171	indication 10132 10167	Vasomotor Symptoms due to Menopause
T173	adversereaction 10339 10358	endometrial cancer.
T175	routeofadministration 10899 10920	applied onto the skin
T177	indication 11066 11101	Vasomotor Symptoms due to Menopause
T179	tradename 11103 11111	ELESTRIN
T181	frequency 11123 11133	once daily
T183	indication 11191 11226	vasomotor symptoms due to menopause
T185	dose 11268 11277	0.87 gram
T187	activeingredient 11281 11290	estradiol
T189	dose 11296 11303	0.52 mg
T191	activeingredient 11304 11314	estradiol)
T193	tradename 11401 11409	ELESTRIN
T195	frequency 11429 11436	per day
T197	dose 11438 11444	0.87 g
T199	frequency 11445 11452	per day
T201	dose 11469 11476	0.52 mg
T203	activeingredient 11480 11490	estradiol)
T205	tradename 11682 11690	Elestrin
T207	activeingredient 11692 11701	estradiol
T209	dose 11764 11771	0.52 mg
T211	activeingredient 11775 11784	estradiol
T213	dose 11788 11794	0.87 g
T215	tradename 11843 11851	ELESTRIN
T217	tradename 12250 12258	ELESTRIN
T219	adversereaction 12454 12478	Cardiovascular Disorders
T221	adversereaction 12501 12507	stroke
T223	adversereaction 12512 12515	DVT
T225	adversereaction 12586 12588	PE
T227	adversereaction 12590 12593	DVT
T229	adversereaction 12595 12601	stroke
T231	adversereaction 12606 12608	MI
T233	adversereaction 13188 13194	stroke
T235	frequency 13249 13254	daily
T237	dose 13259 13268	0.625 mg)
T239	adversereaction 13476 13482	stroke
T241	adversereaction 13644 13650	stroke
T243	dose 13681 13690	0.625 mg)
T245	frequency 13921 13926	daily
T247	dose 13931 13940	0.625 mg)
T249	dose 13951 13958	2.5 mg)
T251	adversereaction 14270 14292	Coronary Heart Disease
T253	adversereaction 14351 14379	coronary heart disease (CHD)
T255	dose 14655 14664	0.625 mg]
T257	frequency 14925 14930	daily
T259	dose 14935 14944	0.625 mg)
T261	dose 14955 14962	2.5 mg)
T263	frequency 15449 15454	daily
T265	dose 15459 15468	0.625 mg)
T267	dose 15479 15486	2.5 mg)
T269	adversereaction 16218 16240	Venous Thromboembolism
T271	frequency 16341 16346	daily
T273	dose 16351 16360	0.625 mg)
T275	frequency 16868 16873	daily
T277	dose 16878 16887	0.625 mg)
T279	dose 16898 16905	2.5 mg)
T281	adversereaction 17563 17582	Malignant Neoplasms
T283	adversereaction 17584 17602	Endometrial Cancer
T285	adversereaction 17625 17643	endometrial cancer
T287	adversereaction 18834 18857	endometrial hyperplasia
T289	adversereaction 18887 18906	endometrial cancer.
T291	tradename 19001 19009	ELESTRIN
T293	dose 19010 19015	1.7 g
T295	frequency 19016 19023	per day
T297	adversereaction 19031 19044	Breast Cancer
T299	adversereaction 19119 19132	breast cancer
T301	frequency 19180 19185	daily
T303	dose 19190 19199	0.625 mg)
T305	frequency 19289 19294	daily
T307	adversereaction 19349 19371	invasive breast cancer
T309	adversereaction 19504 19517	breast cancer
T311	frequency 19574 19579	daily
T313	dose 19584 19593	0.625 mg)
T315	dose 19604 19611	2.5 mg)
T317	adversereaction 19719 19741	invasive breast cancer
T319	frequency 19760 19765	daily
T321	adversereaction 19925 19947	invasive breast cancer
T323	adversereaction 20144 20166	invasive breast cancer
T325	adversereaction 20366 20388	invasive breast cancer
T327	adversereaction 20531 20554	invasive breast cancers
T329	dose 20661 20670	0.625 mg)
T331	dose 20681 20688	2.5 mg)
T333	adversereaction 21457 21470	breast cancer
T335	adversereaction 22899 22916	Probable Dementia
T337	frequency 23054 23059	daily
T339	dose 23064 23073	0.625 mg)
T341	frequency 23674 23679	daily
T343	dose 23684 23693	0.625 mg)
T345	dose 23704 23711	2.5 mg)
T347	adversereaction 23852 23870	probable dementia.
T349	adversereaction 23894 23911	probable dementia
T351	adversereaction 23996 24013	probable dementia
T353	adversereaction 24357 24374	probable dementia
T355	adversereaction 24634 24653	Gallbladder Disease
T357	adversereaction 24694 24713	gallbladder disease
T359	adversereaction 24801 24814	Hypercalcemia
T361	adversereaction 24859 24872	hypercalcemia
T363	adversereaction 24926 24939	hypercalcemia
T365	adversereaction 25053 25073	Visual Abnormalities
T367	adversereaction 25075 25102	Retinal vascular thrombosis
T369	adversereaction 25215 25249	partial or complete loss of vision
T371	adversereaction 25272 25281	proptosis
T373	adversereaction 25283 25291	diplopia
T375	adversereaction 25296 25305	migraine.
T377	adversereaction 25331 25342	papilledema
T379	adversereaction 25346 25370	retinal vascular lesions
T381	adversereaction 25988 26002	breast cancer.
T383	adversereaction 26008 26031	Elevated Blood Pressure
T385	adversereaction 26080 26107	increases in blood pressure
T387	adversereaction 26302 26322	Hypertriglyceridemia
T389	adversereaction 26351 26371	hypertriglyceridemia
T391	adversereaction 26585 26605	Cholestatic Jaundice
T393	adversereaction 26886 26900	Hypothyroidism
T395	adversereaction 27455 27470	Fluid Retention
T397	adversereaction 27507 27523	fluid retention.
T399	adversereaction 27699 27711	Hypocalcemia
T401	adversereaction 27811 27823	hypocalcemia
T403	adversereaction 27841 27870	Exacerbation of Endometriosis
T405	adversereaction 28197 28230	exacerbate symptoms of angioedema
T407	tradename 28634 28642	ELESTRIN
T409	activeingredient 28708 28717	Estradiol
T411	tradename 28788 28796	ELESTRIN
T413	tradename 28912 28921	ELESTRIN.
T415	tradename 28964 28972	ELESTRIN
T417	activeingredient 29034 29043	estradiol
T419	tradename 29098 29106	ELESTRIN
T421	activeingredient 29407 29416	estradiol
T423	activeingredient 30723 30732	estradiol
T425	adversereaction 31192 31216	Cardiovascular Disorders
T427	adversereaction 31274 31293	Malignant Neoplasms
T429	tradename 31650 31658	ELESTRIN
T431	tradename 32063 32071	ELESTRIN
T433	tradename 32093 32101	ELESTRIN
T435	adversereaction 32166 32183	Breast tenderness
T437	adversereaction 32209 32221	Metrorrhagia
T439	adversereaction 32298 32313	Nasopharyngitis
T441	adversereaction 32342 32375	Upper respiratory tract infection
T443	tradename 32512 32521	ELESTRIN.
T445	adversereaction 32749 32825	Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow
T447	adversereaction 32827 32848	breakthrough bleeding
T449	adversereaction 32850 32858	spotting
T451	adversereaction 32860 32872	dysmenorrhea
T453	adversereaction 32874 32913	increase in size of uterine leiomyomata
T455	adversereaction 32915 32924	vaginitis
T457	adversereaction 32936 32955	vaginal candidiasis
T459	adversereaction 32957 32995	change in amount of cervical secretion
T461	adversereaction 32997 33026	changes in cervical ectropion
T463	adversereaction 33028 33042	ovarian cancer
T465	adversereaction 33044 33067	endometrial hyperplasia
T467	adversereaction 33069 33088	endometrial cancer.
T469	adversereaction 33099 33109	Tenderness
T471	adversereaction 33111 33122	enlargement
T473	adversereaction 33124 33128	pain
T475	adversereaction 33130 33146	nipple discharge
T477	adversereaction 33148 33160	galactorrhea
T479	adversereaction 33162 33188	fibrocystic breast changes
T481	adversereaction 33190 33204	breast cancer.
T483	adversereaction 33222 33260	Deep and superficial venous thrombosis
T485	adversereaction 33262 33280	pulmonary embolism
T487	adversereaction 33282 33298	thrombophlebitis
T489	adversereaction 33300 33321	myocardial infarction
T491	adversereaction 33323 33329	stroke
T493	adversereaction 33331 33358	increase in blood pressure.
T495	adversereaction 33379 33385	Nausea
T497	adversereaction 33387 33395	vomiting
T499	adversereaction 33397 33413	abdominal cramps
T501	adversereaction 33415 33423	bloating
T503	adversereaction 33425 33445	cholestatic jaundice
T505	adversereaction 33447 33489	increased incidence of gallbladder disease
T507	adversereaction 33491 33503	pancreatitis
T509	adversereaction 33505 33540	enlargement of hepatic hemangiomas.
T511	adversereaction 33548 33610	Chloasma or melasma that may persist when drug is discontinued
T513	adversereaction 33612 33631	erythema multiforme
T515	adversereaction 33633 33649	erythema nodosum
T517	adversereaction 33651 33671	hemorrhagic eruption
T519	adversereaction 33673 33691	loss of scalp hair
T521	adversereaction 33693 33702	hirsutism
T523	adversereaction 33704 33712	pruritus
T525	adversereaction 33714 33719	rash.
T527	adversereaction 33727 33754	Retinal vascular thrombosis
T529	adversereaction 33756 33786	intolerance to contact lenses.
T531	adversereaction 33812 33820	Headache
T533	adversereaction 33822 33830	migraine
T535	adversereaction 33832 33841	dizziness
T537	adversereaction 33843 33860	mental depression
T539	adversereaction 33862 33868	chorea
T541	adversereaction 33870 33881	nervousness
T543	adversereaction 33883 33900	mood disturbances
T545	adversereaction 33902 33914	irritability
T547	adversereaction 33916 33940	exacerbation of epilepsy
T549	adversereaction 33942 33951	dementia.
T551	adversereaction 33968 33998	Increase or decrease in weight
T553	adversereaction 34000 34030	reduced carbohydrate tolerance
T555	adversereaction 34032 34056	aggravation of porphyria
T557	adversereaction 34058 34063	edema
T559	adversereaction 34065 34076	arthralgias
T561	adversereaction 34078 34088	leg cramps
T563	adversereaction 34090 34107	changes in libido
T565	adversereaction 34109 34118	urticaria
T567	adversereaction 34120 34130	angioedema
T569	adversereaction 34132 34168	anaphylactoid/anaphylactic reactions
T571	adversereaction 34170 34182	hypocalcemia
T573	adversereaction 34184 34206	exacerbation of asthma
T575	adversereaction 34208 34232	increased triglycerides.
T577	tradename 34426 34435	ELESTRIN.
T579	tradename 35187 35195	ELESTRIN
T581	routeofadministration 35398 35402	oral
T583	tradename 35477 35485	ELESTRIN
T585	tradename 35784 35792	ELESTRIN
T587	tradename 35849 35857	ELESTRIN
T589	tradename 36077 36085	ELESTRIN
T591	tradename 36184 36193	ELESTRIN.
T593	frequency 36268 36273	daily
T595	dose 36278 36287	0.625 mg]
T597	frequency 36469 36474	daily
T599	dose 36479 36488	0.625 mg]
T601	dose 36499 36506	2.5 mg]
T603	adversereaction 36837 36854	probable dementia
T605	tradename 37310 37318	ELESTRIN
T607	tradename 37427 37435	ELESTRIN
T609	adversereaction 37507 37513	nausea
T611	adversereaction 37515 37523	vomiting
T613	adversereaction 37525 37542	breast tenderness
T615	adversereaction 37544 37558	abdominal pain
T617	adversereaction 37560 37570	drowsiness
T619	adversereaction 37575 37582	fatigue
T621	adversereaction 37588 37607	withdrawal bleeding
T623	tradename 37683 37691	ELESTRIN
T625	tradename 37767 37775	ELESTRIN
T627	activeingredient 37777 37786	estradiol
T629	activeingredient 37810 37819	estradiol
T631	tradename 37918 37926	ELESTRIN
T633	dose 37945 37952	0.52 mg
T635	activeingredient 37956 37965	estradiol
T637	dose 37969 37975	0.87 g
T639	activeingredient 37985 37994	Estradiol
T641	molecularweight 38161 38167	281.4.
T643	tradename 38221 38229	ELESTRIN
T645	activeingredient 38233 38243	estradiol.
T647	inactiveingredient 38283 38290	ethanol
T649	inactiveingredient 38292 38308	propylene glycol
T651	inactiveingredient 38310 38343	diethylene glycol monoethyl ether
T653	inactiveingredient 38345 38357	carbomer 940
T655	inactiveingredient 38359 38374	triethanolamine
T657	inactiveingredient 38376 38392	edetate disodium
T659	inactiveingredient 38407 38413	water)
T661	activeingredient 38747 38756	estradiol
T663	activeingredient 39023 39032	estradiol
T665	tradename 39894 39903	ELESTRIN.
T667	activeingredient 39977 39986	estradiol
T669	tradename 40055 40063	ELESTRIN
T671	activeingredient 40114 40123	estradiol
T673	dose 40165 40171	0.87 g
T675	dose 40175 40180	1.7 g
T677	tradename 40184 40192	ELESTRIN
T679	tradename 40255 40263	ELESTRIN
T681	dose 40264 40270	0.87 g
T683	dose 40275 40280	1.7 g
T685	activeingredient 40310 40319	estradiol
T687	activeingredient 40504 40513	estradiol
T689	dose 40606 40612	0.87 g
T691	frequency 40613 40620	per day
T693	dose 40625 40630	1.7 g
T695	frequency 40631 40638	per day
T697	frequency 40653 40660	per day
T699	frequency 40675 40682	per day
T701	activeingredient 40749 40758	Estradiol
T703	dose 40810 40816	0.87 g
T705	tradename 40817 40825	ELESTRIN
T707	dose 40827 40835	0.52 mg/
T709	frequency 40835 40836	d
T711	activeingredient 40837 40847	Estradiol)
T713	dose 40853 40858	1.7 g
T715	tradename 40859 40867	ELESTRIN
T717	dose 40869 40877	1.04 mg/
T719	frequency 40877 40878	d
T721	activeingredient 40879 40889	Estradiol)
T723	auc 40903 40922	(hr/mL) 335.2 940.2
T725	auc 40923 40927	Cmax
T727	cmax 40928 40945	(pg/mL) 21.6 66.7
T729	cmax 40946 40950	Cave
T731	tmax 40996 41003	(h)a 18
T733	tmax 41005 41014	1 - 20) 4
T735	activeingredient 41117 41127	estradiol:
T737	activeingredient 41167 41176	estradiol
T739	activeingredient 41256 41265	Estradiol
T741	dose 41434 41440	0.87 g
T743	dose 41458 41463	1.7 g
T745	dose 41518 41523	1.7 g
T747	dose 41585 41590	1.7 g
T749	tradename 41599 41607	ELESTRIN
T751	tradename 41814 41822	ELESTRIN
T753	activeingredient 41849 41858	estradiol
T755	activeingredient 41915 41924	estradiol
T757	tradename 42006 42015	ELESTRIN.
T759	tradename 42108 42116	ELESTRIN
T761	activeingredient 42151 42160	estradiol
T763	tradename 42246 42255	ELESTRIN.
T765	activeingredient 42787 42796	Estradiol
T767	activeingredient 43358 43367	Estradiol
T769	activeingredient 43624 43633	Estradiol
T771	activeingredient 43662 43671	estradiol
T773	dose 43815 43820	2.6 g
T775	tradename 43821 43829	ELESTRIN
T777	activeingredient 43973 43982	estradiol
T779	activeingredient 44089 44098	estradiol
T781	activeingredient 44283 44292	estradiol
T783	frequency 44774 44779	daily
T785	tradename 44789 44797	ELESTRIN
T787	activeingredient 45079 45088	estradiol
T789	tradename 45196 45204	ELESTRIN
T791	dose 45205 45210	1.7 g
T793	dose 45212 45219	1.04 mg
T795	activeingredient 45220 45230	estradiol)
T797	dose 45235 45240	2.6 g
T799	dose 45242 45249	1.56 mg
T801	activeingredient 45250 45260	estradiol)
T803	frequency 45261 45271	once daily
T805	tradename 45355 45363	ELESTRIN
T807	dose 45412 45417	2.6 g
T809	tradename 45453 45461	ELESTRIN
T811	dose 45462 45468	0.87 g
T813	dose 45470 45477	0.52 mg
T815	activeingredient 45478 45488	estradiol)
T817	dose 45507 45512	2.6 g
T819	tradename 45674 45682	ELESTRIN
T821	dose 45683 45688	1.7 g
T823	frequency 45689 45696	per day
T825	tradename 45887 45895	ELESTRIN
T827	dose 45896 45902	0.87 g
T829	frequency 45903 45910	per day
T831	dose 45938 45944	0.87 g
T833	frequency 45945 45952	per day
T835	dose 45957 45962	1.7 g
T837	frequency 45963 45970	per day
T839	dose 46211 46216	1.7 g
T841	frequency 46217 46224	per day
T843	tradename 46225 46233	ELESTRIN
T845	tradename 46411 46419	ELESTRIN
T847	tradename 46458 46466	ELESTRIN
T849	dose 46467 46474	0.87 g/
T851	frequency 46474 46477	day
T853	tradename 46486 46494	ELESTRIN
T855	dose 46495 46501	1.7 g/
T857	frequency 46501 46504	day
T859	frequency 47478 47483	daily
T861	routeofadministration 47484 47488	oral
T863	dose 47493 47502	0.625 mg)
T865	dose 47537 47544	2.5 mg)
T867	frequency 55301 55306	daily
T869	dose 55311 55320	0.625 mg)
T871	frequency 56443 56448	daily
T873	dose 56453 56462	0.625 mg)
T875	dose 56473 56480	2.5 mg)
T877	tradename 59251 59259	Elestrin
T879	activeingredient 59264 59273	estradiol
T881	dose 59718 59724	0.87 g
T883	dose 59747 59754	0.52 mg
T885	activeingredient 59758 59768	estradiol.
T887	tradename 59983 59991	ELESTRIN
T889	tradename 60057 60065	ELESTRIN
T891	adversereaction 60673 60697	Cardiovascular Disorders
T893	adversereaction 60699 60718	Malignant Neoplasms
T895	adversereaction 60724 60741	Probable Dementia
T897	adversereaction 60992 61000	headache
T899	adversereaction 61002 61028	breast pain and tenderness
T901	adversereaction 61030 61036	nausea
T903	adversereaction 61041 61050	vomiting.
T905	tradename 61084 61094	ELESTRINTM
T907	activeingredient 61096 61105	estradiol
T909	tradename 61165 61173	ELESTRIN
T911	tradename 61222 61230	ELESTRIN
T913	tradename 61469 61477	ELESTRIN
T915	adversereaction 61566 61580	 of the uterus
T917	tradename 61655 61664	ELESTRIN.
T919	adversereaction 61725 61745	cancer of the uterus
T921	adversereaction 62104 62112	dementia
T923	adversereaction 62331 62344	heart attacks
T925	adversereaction 62346 62353	strokes
T927	adversereaction 62355 62368	breast cancer
T929	adversereaction 62373 62384	blood clots
T931	adversereaction 62454 62462	dementia
T933	tradename 62612 62620	ELESTRIN
T935	tradename 62630 62639	ELESTRIN?
T937	tradename 62641 62649	ELESTRIN
T939	activeingredient 62718 62728	estradiol)
T941	routeofadministration 62738 62763	absorbed through the skin
T943	tradename 62795 62803	ELESTRIN
T945	tradename 62815 62823	ELESTRIN
T947	indication 62853 62890	Reduce moderate to severe hot flashes
T949	tradename 63760 63769	ELESTRIN.
T951	tradename 63790 63799	ELESTRIN?
T953	tradename 63820 63828	ELESTRIN
T955	tradename 64123 64132	ELESTRIN.
T957	tradename 64309 64317	ELESTRIN
T959	tradename 64375 64383	ELESTRIN
T961	tradename 65167 65175	ELESTRIN
T963	tradename 65184 65192	ELESTRIN
T965	tradename 65324 65333	ELESTRIN.
T967	tradename 65375 65383	ELESTRIN
T969	tradename 65434 65443	ELESTRIN?
T971	tradename 65559 65567	ELESTRIN
T973	tradename 65822 65831	ELESTRIN.
T975	tradename 65833 65841	ELESTRIN
T977	tradename 65885 65893	ELESTRIN
T979	tradename 65959 65967	ELESTRIN
T981	tradename 66021 66029	ELESTRIN
T983	tradename 66835 66844	ELESTRIN.
T985	tradename 67009 67017	ELESTRIN
T987	tradename 67267 67275	ELESTRIN
T989	tradename 67668 67677	ELESTRIN.
T991	tradename 67795 67803	ELESTRIN
T993	tradename 67832 67840	ELESTRIN
T995	tradename 68154 68162	ELESTRIN
T997	tradename 68349 68357	ELESTRIN
T999	tradename 68431 68440	ELESTRIN?
T1001	tradename 68472 68480	ELESTRIN
T1003	tradename 68833 68841	ELESTRIN
T1005	tradename 68866 68874	ELESTRIN
T1007	tradename 68955 68964	ELESTRIN.
T1009	tradename 69383 69392	ELESTRIN?
T1011	adversereaction 69543 69555	Heart attack
T1013	adversereaction 69557 69563	Stroke
T1015	adversereaction 69565 69576	Blood clots
T1017	adversereaction 69578 69586	Dementia
T1019	adversereaction 69588 69601	Breast cancer
T1021	adversereaction 69603 69637	Cancer of the lining of the uterus
T1023	adversereaction 69646 69665	Cancer of the ovary
T1025	adversereaction 69667 69686	High blood pressure
T1027	adversereaction 69688 69704	High blood sugar
T1029	adversereaction 69706 69725	Gallbladder disease
T1031	adversereaction 69727 69741	Liver problems
T1033	adversereaction 69743 69785	Enlargement of benign tumors of the uterus
T1035	adversereaction 70180 70188	Headache
T1037	adversereaction 70190 70201	Breast pain
T1039	adversereaction 70203 70241	Irregular vaginal bleeding or spotting
T1041	adversereaction 70243 70270	Stomach or abdominal cramps
T1043	adversereaction 70272 70280	bloating
T1045	adversereaction 70282 70301	Nausea and vomiting
T1047	adversereaction 70303 70312	Hair loss
T1049	adversereaction 70314 70329	Fluid retention
T1051	adversereaction 70331 70354	Vaginal yeast infection
T1053	tradename 70403 70412	ELESTRIN.
T1055	company 70544 70564	Meda Pharmaceuticals
T1057	tradename 70678 70687	ELESTRIN?
T1059	tradename 70774 70782	ELESTRIN
T1061	tradename 71114 71123	ELESTRIN.
T1063	tradename 71729 71737	ELESTRIN
T1065	tradename 71858 71866	ELESTRIN
T1067	tradename 71928 71936	ELESTRIN
T1069	tradename 72026 72034	ELESTRIN
T1071	tradename 72137 72146	ELESTRIN.
T1073	tradename 72271 72279	ELESTRIN
T1075	tradename 73178 73186	ELESTRIN
T1077	tradename 73317 73326	ELESTRIN.
T1079	tradename 73364 73372	ELESTRIN
T1081	frequency 73395 73400	daily
T1083	tradename 73496 73504	ELESTRIN
T1085	tradename 73641 73649	ELESTRIN
T1087	tradename 73688 73696	ELESTRIN
T1089	tradename 74139 74147	ELESTRIN
T1091	tradename 74255 74264	ELESTRIN?
T1093	activeingredient 74285 74295	estradiol.
T1095	inactiveingredient 74328 74333	water
T1097	inactiveingredient 74335 74342	ethanol
T1099	inactiveingredient 74344 74360	propylene glycol
T1101	inactiveingredient 74362 74395	diethylene glycol monoethyl ether
T1103	inactiveingredient 74397 74409	carbomer 940
T1105	inactiveingredient 74411 74426	triethanolamine
T1107	inactiveingredient 74432 74449	edetate disodium.
T1109	tradename 74451 74459	ELESTRIN
T1111	company 74478 74498	Meda Pharmaceuticals
T1113	company 74517 74537	Meda Pharmaceuticals
T1115	company 74630 74646	DPT Laboratories
T1117	company 74648 74652	Ltd.
T1119	u.s.patent 74705 74706	7
T1121	u.s.patent 74707 74710	198
T1123	u.s.patent 74711 74714	801
T1125	u.s.patent 74733 74734	7
T1127	u.s.patent 74735 74738	470
T1129	u.s.patent 74739 74742	433
